Table 2. Summary of meta-analysis results.
| N | Model | Pooled OR (95% CI) | P value | Heterogeneity(P, I2) | Publication bias | Conclusion | |
|---|---|---|---|---|---|---|---|
| Total | 4 | Random | 15.61 (4.09-59.61) | <0.001 | 0.086, 54.5% | 0.308 | Positive |
| Asian | 2 | Fixed | 69.61 (14.05-344.93) | <0.001 | 0.896, 0.0% | 1.000 | Positive |
| Non-Asian | 2 | Fixed | 5.86 (2.11-16.24) | 0.001 | 0.831, 0.0% | 1.000 | Positive |
| Prospective | 3 | Fixed | 8.56 (3.36-21.78) | <0.001 | 0.187, 40.3% | 1.000 | Positive |
| Retrospective | 1 | — | 77.00 (8.53-694.81) | <0.05 | — | — | Positive |
| VF | 3 | Random | 25.38 (4.31-149.65) | <0.001 | 0.076, 61.2% | 1.000 | Positive |
| VA | 1 | — | 5.10 (1.00-26.30) | 0.034 | — | — | Positive |
| Follow-up ≥ 3 months | 3 | Random | 25.12 (3.88-162.67) | 0.001 | 0.081, 60.2% | 1.000 | Positive |
| Follow-up < 3 months | 1 | — | 6.40 (1.70-23.10) | 0.007 | — | — | Positive |
| Pituitary adenoma | 2 | Random | 15.41 (1.35-175.70) | 0.028 | 0.085, 66.2% | 1.000 | Positive |
| Other tumor types | 2 | Random | 18.84 (1.68-211.09) | 0.017 | 0.057, 72.5% | 1.000 | Positive |
| Transsphenoidal | 2 | Random | 15.41 (1.35-175.70) | 0.028 | 0.085, 66.2% | 1.000 | Positive |
| Transcranial/unknown | 2 | Random | 18.84 (1.68-211.09) | 0.017 | 0.057, 72.5% | 1.000 | Positive |
VF visual field, VA visual acuity, N number of included studies, OR odds ratio, CI, confidence interval.